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Aim: To investigate the effect of insulin on receptor activator of nuclear factor kappa-B ligand (RANKL) and osteoprotegerin (OPG)
expression in human osteosarcoma MG63 cells using real-time polymerase chain reaction.
Materials and methods: MG63 cells were exposed to different concentrations of human recombinant insulin (1, 10, and 100 nM) for 24
h, and then the expression of RANKL and OPG mRNA was identified.
After that, MG63 cells were exposed to tensile stress
combined with 0 or 10 nM insulin respectively for 0, 3, 6, and 12 h, and then the expression of RANKL and OPG mRNA was identified.
Human monocytes were cultured with the collected culture media from MG63 cells plates that were exposed to different concentrations
of human recombinant insulin (0 and 10 nM) for 7 days, and then were stained with an acid phosphatase kit.
Results: After 24 h of treatment with 1, 10, and 100 nM doses of insulin, the expression of RANKL and OPG mRNA was suppressed (P
< 0.05), and the ratio of OPG to RANKL also was suppressed (P < 0.05). Application of tensile stress to MG63 cells induced a decrease in
RANKL mRNA expression and an increase in OPG mRNA expression at 6 and 12 h (P < 0.05); 10 nM insulin decreased the mechanical
stress-induced RANKL and OPG mRNA expression in MG63 cells at 6 and 12 h (P < 0.05). The ratio of OPG to RANKL increased at 6
and 12 h in the 2 groups (P < 0.05), but insulin decreased the mechanical stress-induced OPG/RANKL ratio at 12 h (P < 0.05). For the
group of monocytes cultured with DMEM collected from MG63 cells plates that were cultured with 0 nM human recombinant insulin,
osteoclast formation was not observed. Osteoclast formation was observed in monocytes cultured with DMEM collected from MG63
cells plates that were cultured with 10 nM human recombinant insulin.
Conclusion: These results suggest that insulin can modulate osteoclast differentiation via altering the OPG and RANKL expression in
osteoblasts. The deficiency in insulin may decrease the number of osteoclasts and osteoclast-mediated bone resorption in patients with
type 1 diabetes mellitus.
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1. Introduction
It is well established that type 1 diabetes mellitus (T1DM),
which is insulin-dependent, is associated with retinopathy,
cardiovascular symptoms, sexual dysfunction, and
other complications (1,2). Recent studies also found
that alteration in bone metabolism (low bone-mineral
density, osteopenia, osteoporosis, etc.) is common in
T1DM patients (3–5), which suggests that insulin acts as a
regulator in bone metabolism. The accumulating evidence
implies that insulin can regulate bone metabolism by
facilitating bone formation through promoting osteoblast
proliferation and differentiation (6,7), but whether insulin
can regulate osteoclast-mediated bone resorptive activity
remains unclear.
Besides being involved in bone formation, osteoblasts
can modulate osteoclast differentiation by expressing
a specific osteoclast differentiation factor, the receptor
* Correspondence: xinchun112@126.com

activator of nuclear factor kappa-B ligand (RANKL), and
its decoy receptor, osteoprotegerin (OPG). RANKL is
indispensable in osteoclast differentiation (8). Acting as a
decoy receptor by blocking the interaction of RANKL with
its functional receptor RANK, OPG can inhibit osteoclast
differentiation and osteoclastogenesis (9). The ratio
between OPG and RANKL expression levels in osteoblasts
determines the osteoclast differentiation (8–10).
Mechanical loading is a key factor in regulating bone
remodeling (11). Besides mechanical loading, numerous
factors (including growth factors and systemic hormones)
can influence bone remodeling (12). Osteoblasts may
exhibit distinct responses to mechanical stimulus under
various in vivo conditions, as we can see in defective
cellular responses to mechanical loading in patients with
musculoskeletal diseases, for example the patients with
disuse osteoporosis, senile osteoporosis, or osteoarthritis
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(13,14). In vitro studies demonstrate that mechanical
stimulus reduces RANKL expression but up-regulates the
OPG expression in osteoblasts (15–17). However, whether
insulin modulates mechanical stress-induced RANKL and
OPG expression in osteoblasts remains unclear.
The aim of this study was to investigate the effects of
insulin on the RANKL and OPG expression in osteoblasts
for the purpose of making clear whether the decrease
of insulin can impact the RANKL and OPG expression
in osteoblasts and consequently influence osteoclast
differentiation in patients with T1DM.
2. Materials and methods
2.1. Materials
Human osteosarcoma MG63 cell was obtained from
ATCC (Manassas, VA, USA). Dulbecco’s modified Eagle’s
medium (DMEM) was purchased from Gibco-BRL (Grand
Island, NY, USA). Fetal bovine serum (FBS) was obtained
from HyClone (Logan, UT, USA). Insulin was from Sigma
(St. Louis, MO, USA). The First Strand cDNA Synthesis
Kit was from Fermentas UAB (Vilnius, Lithuania). The
tartrate-resistant acid phosphatase (TRAP) kit was from
Nanjing Jiancheng Bioengineering Institute (Nanjing,
China). The LightCycler 480 SYBR Green I Master was
purchased from Roche Applied Science (Branford, CT,
USA).
2.2. Cell culture
Cells were cultured in DMEM supplemented with 10%
FBS and 1% penicillin/streptomycin. After reaching
confluence, these cells were trypsinized and seeded into
6-well plates at a density of 1 × 105 cells/well. The cells
were left undisturbed in the incubator for 24 h, and then
the medium was changed to FBS-free medium for 24 h
for equalizing cell growth prior to experiments. The cells
were then exposed to different concentrations of human
recombinant insulin for 24 h.
Human monocytes were isolated from freshly
collected buffy coats discarded from healthy adult donors
by Ficoll-Hypaque density gradient centrifugation. The
separated lymphomonocytes were washed with PBS and
resuspended in DMEM supplement with 10% FBS and 1%
penicillin/streptomycin.
2.3. Applying mechanical stress
Cells were seeded on the force-loading plate at a density of
1 × 104 cells/cm2. The force-loading plates were made by
using a method described previously (18). The cells were
incubated in DMEM supplemented with 10% FBS and 1%
penicillin/streptomycin for 48 h. The medium was then
changed to FBS-free medium for 24 h for equalizing cell
growth prior to experiments. The cells were then loaded
with tensile stress at 2000 u-strain and 0.5 Hz, which
has been characterized and described in detail elsewhere
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(18). In the control group, cells were subjected to similar
treatment but without mechanical stress stimulus.
2.4. RNA isolation and real-time PCR
After the cells were harvested, total RNA was extracted
and quantified using the method described previously
(18). RNA was reverse-transcribed using the First
Strand cDNA Synthesis Kit following the manufacturer’s
instructions. The cDNA was then amplified through realtime polymerase chain reaction (PCR) using LightCycler.
Sequences of all PCR primers are shown in the Table.
Data were analyzed using the 2–ΔΔCT method of Livak and
Schmittgen (19), using the housekeeping gene β-actin to
calculate the ΔCT, and using the control at each time point
to calculate the –ΔΔCT.
2.5. TRAP staining
MG63 cells were cultured with different concentrations of
human recombinant insulin (0 nM, 10 nM) for 24 h, and
then the culture media were collected.
After reaching confluence, the monocytes were
trypsinized and seeded into the 6-well plates at a density
of 1 × 104 cells/well. The cells were cultured with the
collected culture media as mentioned above. The culture
media were completely removed and replaced every 2
days thereafter. On day 7, the cells were stained for TRAP
with an acid phosphatase kit as instructed in the product
manual. Cells containing 3 or more nuclei were considered
a multinuclear cell.
2.6. Statistical analyses
Results are shown as mean ± SD. Statistical analysis was
performed with SPSS using the independent Student’s t-test
for 2 groups of data and analysis of variance (ANOVA).
The difference was considered significant at P < 0.05.
3. Results
3.1. Effect of insulin on RANKL and OPG mRNA
expression
MG63 cells were treated with different doses of insulin
(1, 10, 100 nM) for 24 h. RANKL (Figure 1A) and OPG
(Figure 1B) mRNA expression was determined by realtime PCR. Data are presented as percentage changes
relative to the unstimulated control cells (normalized to
β-actin gene expression). As shown in Figures 1A and 1B,
after 24 h of treatment with 1, 10, and 100 nM doses of
insulin, the expression of RANKL and OPG mRNA was
suppressed (P < 0.05), and the ratio of OPG to RANKL
was also suppressed (P < 0.05) (Figure 1C).
3.2. Insulin modulates tensile stress-induced OPG and
RANKL mRNA expression in MG63 cells
MG63 cells were exposed to tensile stress combined
with 0 or 10 nM insulin respectively for 0, 3, 6, and 12 h.
Data are presented as percentage changes relative to the
unstimulated control cells (normalized to β-actin gene
expression). As shown in Figures 2A and 2B, application
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Table. Primer sequences used for real-time PCR.
Size
(bp)

1.2
1
0.8
0.6
0.4
0.2
0

(%ofcontrol cells)
OPG/RANKL

(% of control cells)
mRNA expression
OPG

(% of control cells)
mRNA expression
RANKL

Gene name Primer sequence
		

1.2
1
0.8
0.6
0.4
0.2
0
1.2
1
0.8
0.6
0.4
0.2
0

RANKL

AGAGCGCAGATGGATCCTAA
TTCCTTTTGCACAGCTCCTT

180		

56

OPG

GCAGCGGCACATTGGAC
CCCGGTAAGCTTTCCATCAA

69		

60

β-actin

AAATCGTCCGTGACATCAAG
GGAAGGAAGGCTGG AAGA GA

180		

60

2

a

Annealing Temperature
(Celsius)

*

*

*

1.5
1

stress
+insulin
stress

0

1 nm

10 nm

100 nm

b

*

0
c

1 nm
*

*

10 nm

*

100 nm

5
4
3
2
1
0
16
12

*

0
1 nm
10 nm
*p<0.05 versus unstimulated control cells.

*

8

0h

3h

Figure 1. Effect of insulin on RANKL (A) and OPG (B) mRNA
expression, and the ratio of those expressions (C). *: P < 0.05
versus unstimulated control cells.

of tensile stress to MG63 cells induced a decrease in
RANKL mRNA expression and an increase in OPG
mRNA expression at 6 and 12 h (P < 0.05); 10 nM insulin
decreased the mechanical stress-induced RANKL and
OPG mRNA expression in MG63 cells at 6 and 12 h (P
< 0.05). The ratio of OPG to RANKL increased at 6 and
12 h in the 2 groups (P < 0.05), but insulin decreased the
mechanical stress-induced OPG-to-RANKL ratio at 12 h
(P < 0.05) (Figure 2C).
3.3. Effect of insulin on osteoclast differentiation
For the group of monocytes cultured with DMEM collected
from the MG63 cell plates that were cultured with 0 nM
human recombinant insulin, osteoclast formation was not
observed (Figure 3A). Osteoclast formation was observed

0

6h

12 h
*#
*#

*

*
0h

3h

6h

stress
+insulin
stress

12 h
*#
*

*
0h

*#

*

stress
+insulin
stress

4
100 nm

*#

*

0.5
0

		

3h

*
6h

12 h

Figure 2. Effect of insulin on mechanical stress-induced RANKL
(A) and OPG (B) mRNA expression, and the ratio of those
expressions (C). *: P < 0.05 versus unstimulated control cells. #: P
< 0.05 versus the cells that were treated with 10 nM insulin and
exposed to tensile stress for equal time.

in monocytes cultured with DMEM collected from
MG63 cell plates that were cultured with 10 nM human
recombinant insulin (Figure 3B).
4. Discussion
Controversy exists as to whether insulin can affect bone
resorptive activity. Some previous studies indicated a
decrease in the number of osteoclasts in type 1 diabetic
rodent (20–22). On the other hand, several groups have
reported higher levels of TRAP activity and an increased
number of osteoclasts was observed in type 1 diabetic
rodent (23–26).
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In this regard, this study aimed to investigate the
potential effect of insulin on RANKL and OPG expression
in osteoblasts for the purpose of investigating the effect
of insulin on osteoclast differentiation. We found that
insulin suppressed RANKL mRNA expression in a dosedependent manner. These results indicate that insulin
modulates RANKL expression in osteoblasts and the
deficiency in insulin may decrease the RANKL level in
patients with T1DM. However, the potential cellular
mechanism remains unclear. Several studies have
demonstrated that insulin receptor substrates (IRS-1 and
IRS-2) that mediate intracellular signaling by insulin and
IGF are essential for the RANKL expression in osteoclasts
(27–29). To make clear the potential cellular mechanism
of RANKL expression regulated by insulin, future studies
can take into account these 2 substrate-mediated signaling
pathways activated by insulin in osteoblasts.
OPG, acting as a decoy receptor, plays a crucial role
in inhibiting osteoclast differentiation by blocking the
RANK–RANKL interaction (9). We therefore tested
whether the expression of OPG mRNA was affected by
insulin. We found that insulin decreased the OPG mRNA
expression in MG63 cells in a dose-dependent manner.
The results imply that the deficiency in insulin increases
the OPG level in patients with T1DM. This may support
previous in vivo studies that demonstrated that patients
with T1DM have a significant increase of OPG serum
levels and that it can be normalized after insulin treatment
(30,31). As OPG is known to exert an antiresorptive effect
on bone, and many patients with T1DM have osteoporosis
(3,5), the insulin-induced decrease of OPG expression in
MG63 cell was unexpected. Further studies are needed to
determine the underlying mechanisms.
Although insulin decreases both the RANKL and
OPG mRNA expression, the ratio of OPG to RANKL
decreased in a dose-dependent manner in our study.
As described in Section 1, the ratio of OPG to RANKL
expressed in the osteoblasts is a key factor in osteoclast
differentiation. These results imply that insulin promotes
osteoclast differentiation by decreasing the ratio of OPG to
RANKL in osteoblasts and indicate that the deficiency in
insulin decreases the number of osteoclasts and the level of
TRAP activity in patients with T1DM. TRAP staining also
supported the hypothesis. These results are consistent with
data from experiments in which the number of osteoclasts
decreases in rodents with T1DM (20–22).
In this study, we found that tensile stress increased the
ratio of OPG to RANKL in MG63 cells. This result agrees
with the findings of Kaneuji, who found that mechanical
loading inhibited osteoclastogenesis by increasing the ratio
of OPG to RANKL in osteoblasts (32). We demonstrated
that 10 nM insulin decreased the mechanical stressinduced RANKL and OPG mRNA expression (at 6 and
12 h) and the ratio of OPG to RANKL (only at 12 h) in
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a

b

Figure 3. Effect of insulin on osteoclast differentiation: A)
0 nM insulin, B) 10 nM insulin, 40× magnification. Cells
containing 3 or more nuclei were considered as a multinuclear
cell.

MG63 cells. These results suggest that compared with
normal people, the deficiency in insulin results in a
smaller number of osteoclasts induced by osteoblasts
under mechanical condition in patients with T1DM. These
results also indicated that temporal change of insulin level
has no effects on RANKL and OPG mRNA expression or
their ratio in osteoblasts under mechanical conditions.
In summary, the data presented here support the
hypothesis that insulin can influence bone remodeling
though regulating bone resorption by changing the ratio
of OPG to RANKL expressed in osteoblasts. We found that
insulin decreased the ratio of OPG to RANKL in MG63
cells. These results imply that the deficiency in insulin
may decrease the number of osteoclasts and osteoclastmediated bone resorption in patients with T1DM. The
etiopathogenesis of osteoporosis in these patients may be
a reduction of bone formation but not an increase in bone
resorption. These results suggest that insulin can modulate
osteoclast differentiation via altering the OPG and RANKL
expression in osteoblasts. The deficiency in insulin
may decrease the number of osteoclasts and osteoclastmediated bone resorption in patients with T1DM.
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